Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 451 - 500 out of 1,408

Document Document Title
JP4610734B2  
JP2010280701A
To provide a pharmaceutical formulation for administration by inhalation having a therapeutically useful effect in the treatment of inflammatory disorders of the respiratory tract.The pharmaceutical formulation containing a compound of f...  
JP4589869B2  
JP4580041B2  
JP4580242B2  
JP4549625B2  
JP4545929B2  
JP4541166B2  
JP2010529082A
((I) -- the sign in a formula has the meaning explained in the specification -- in order to prevent and/or deal with the obstructive blood vessel pathological change after vascular surgery, it is a compound of formula (I) for manufacture...  
JP4530851B2  
JP2010159211A
To provide a new method for producing a withanolide compound. There is provided a method for producing a compound represented by formula (2) (wherein, R1, R2are each H, methyl or the like; R3, R4are each H or OH; R5is OH, a sugar chain, ...  
JP4508651B2  
JP4495456B2  
JP4474101B2  
JP4464679B2  
JP2010100529A
To provide an ADHD-related disease medicine exhibiting simple and high effects.There is provided a compound of structural formula (1), wherein R1 and R2 are each independently H, OH, a sugar moiety, or the like.  
JP2010095528A
To provide a non-thermally reversible photochromic compound.The invention relates to a photochromic compound which may be thermally reversible or non-thermally reversible, and the like. The invention also relates to a photochromic dichro...  
JP2010077145A
To provide a novel androstane anti-inflammatory and antiallergic compound and a method of preparing the same.This compound is represented by formula (I), and solvates of the same, compositions containing the compound, a method of prepari...  
JP2010509386A
The present invention relates to the progesterone receptor antagonist of general formula I : Inside R1 of a formula can be a hydrogen atom, and R2 can be a hydroxyl machine, or R1 and R2 can become together, and it can be an oxo group.  
JP4436041B2  
JP4427900B2  
JP2010503711A
Use of ginsenoside Compound-K, which structural formula is the following: in manufacturing medicaments for prevention or treatment of arthritis.  
JP2010500323A
In the mammals object for which the present invention has the high number for [for / for / old / the mammals / which have a low serum DHEAS value / the mammals / which have high serum cortisol / DHEAS ratio] the mammals of neutrophils, U...  
JP2009256388A
To provide a new hybrid drug for cancer treatment and for releasing the drug by setting a target on cancer cells.Provided is a hybrid drug for cancer treatment, having a targeting moiety specifically bonding with proteins, receptors and ...  
JP4338306B2  
JPWO2009110612A
The present invention makes it a subject to find out the new function of a brown rice sprout component, its safety is high, it is possible also for continuous ingestion, can also be manufactured in large quantities, and offers a subject ...  
JP2004505989A5  
JP2001518477A5  
JP4272518B2  
JP2009102226A
To provide a drug for recovery from a spinal cord injury recovery exhibiting simple and high effects, to provide a food, a medicine composition containing the same, and to provide a spinal cord injury recovery method.Provided is Withanos...  
JP4263817B2  
JP2009515828A
The disclosure provides androsterone derivatives. The derivatives of the disclosure are useful in the treatment of androgen- and estrogen-associated diseases and disorders, including breast cancer.  
JP2009512422A
The present invention indicates bone formation and anti-adipose cell formation オキシ sterol. A medicine and a method of protecting stromal marrow cells from inhibitory action of oxidant stress to osteoblast differentiation, and block...  
JP2009508877A
The constituent containing ginsenoside of the quantity which increased, polyacetylene, oil refinement, and/or many sugar is explained with a suitable sampling process.  
JP2009046441A
To provide a new cholesterol derivative having little toxicity to a living body, having a high encapsulation rate, and high solubility in supercritical carbon dioxide, providing excellent contrastradiography not only of the systemic bloo...  
JP2009035552A
To provide 17-esters of 9,21-dihalo-pregnane-11,17-diol-20-one.An improved process for the preparation of 17-esters of 9,21-dihalo-pregnane-11,17-diol-20-one is provided. This new process is especially appropriate for the preparation of ...  
JP2007524627A5  
JP2009500385A
:in inhibitor [type of core 2 GlcNAc*T of formula (I) of therapeutically effective quantity which treats patient who needs medical treatment for harmful condition of enzyme core 2 GlcNAc*T which is related active R1は, H, C1*6アルキ...  
JP2008285448A
To provide a new sialidase inhibitor effective for inhibiting the activity of sialidase of influenza virus, etc.The sialidase inhibitor is composed of a derivative obtained by introducing a substituent having an aromatic ring on the 9-si...  
JP2008285497A
To provide a corticosteroid effective in treating disorder of airway passage and lung such as asthma, manifesting a low bioavailability and low systemic side effect in administering by an intranasal administration or oral inhalation.The ...  
JP4187437B2  
JP4180882B2  
JP4169777B2  
JP4162739B2  
JP4162703B2  
JP4147038B2  
JP2004504403A5  
JP4145350B2  
JP2008195667A
To provide a 2-6 sialyl 6-sulfo sugar chain compound bonded with a lipid, or its salt, usable as an anticancer agent and an immunoregulating agent.This compound having a 2-6 sialyl 6-sulfo sugar chain bonded with cholestanol, cholesterol...  
JP2008534638A
Formula (I) characterized by being a triangle board-like form substantially Crystalline particle offer of the non-solvation form 1 many models of the compound of [化 1] is made.  

Matches 451 - 500 out of 1,408